Ignite Creation Date:
2025-12-24 @ 12:57 PM
Ignite Modification Date:
2025-12-24 @ 12:57 PM
Study NCT ID:
NCT03591861
Status:
TERMINATED
Last Update Posted:
2022-12-12
First Post:
2018-06-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
Sponsor:
Washington University School of Medicine
Organization:
Study Overview
Official Title:
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
Status:
TERMINATED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will develop the concept of a sex-specific therapeutic intervention for gliomas that is based upon dietary carbohydrate restriction. The investigators will integrate metabolomics tools and FDG-PET imaging to validate the ketogenic diet on a sex-specific basis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: